Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-02-28 Sale | 2022-03-02 3:34 pm | Karyopharm Therapeutics Inc. | KPTI | Frenkel Ran EVP, Chief Dev. Officer | 1,663 | $10.24 | $17,025 | 258,290 (Direct) | View |
| 2022-02-17 Sale | 2022-02-22 4:16 pm | Karyopharm Therapeutics Inc. | KPTI | Frenkel Ran EVP, Chief Dev. Officer | 2,929 | $12.12 | $35,509 | 101,703 (Direct) | View |
| 2022-02-07 Sale | 2022-02-09 5:26 pm | Karyopharm Therapeutics Inc. | KPTI | Frenkel Ran EVP, Chief Dev. Officer | 1,991 | $9.862 | $19,635 | 104,632 (Direct) | View |
| 2021-02-18 Sale | 2021-02-22 8:11 pm | Karyopharm Therapeutics Inc. | KPTI | Frenkel Ran EVP, Chief Dev. Officer | 2,887 | $14.83 | $42,818 | 46,126 (Direct) | View |
| 2021-02-11 Sale | 2021-02-17 6:47 pm | Karyopharm Therapeutics Inc. | KPTI | Frenkel Ran EVP, Chief Dev. Officer | 2,046 | $15.52 | $31,752 | 68,363 (Direct) | View |
| 2020-05-07 Sale | 2020-05-11 4:26 pm | Karyopharm Therapeutics Inc. | KPTI | Frenkel Ran Chief Dev Operations Officer | 1,974 | $20 | $39,480 | 35,088 (Direct) | View |
| 2020-02-19 Sale | 2020-02-21 5:57 pm | Karyopharm Therapeutics Inc. | KPTI | Frenkel Ran Chief Dev Operations Officer | 2,975 | $16.48 | $49,034 | 36,066 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-02-28 Option Award | 2022-03-02 3:34 pm | N/A 2032-02-27 | Karyopharm Therapeutics Inc. | KPTI | Frenkel Ran EVP, Chief Dev. Officer | 158,250 | $0 | 258,290 (Direct) | View |
| 2021-02-25 Option Award | 2021-03-01 8:12 pm | N/A 2031-02-24 | Karyopharm Therapeutics Inc. | KPTI | Frenkel Ran EVP, Chief Dev. Officer | 81,981 | $0 | 164,407 (Direct) | View |
| 2021-02-15 Exercise | 2021-02-17 6:47 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Frenkel Ran EVP, Chief Dev. Officer | 9,675 | $0 | 68,363 (Direct) | View |
| 2021-02-05 Exercise | 2021-02-09 8:33 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Frenkel Ran EVP, Chief Dev. Officer | 5,650 | $0 | 58,334 (Direct) | View |
| 2020-02-15 Exercise | 2020-02-19 6:12 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Frenkel Ran Chief Dev Operations Officer | 9,675 | $0 | 68,066 (Direct) | View |
| 2020-02-05 Option Award | 2020-02-07 4:19 pm | N/A 2030-02-04 | Karyopharm Therapeutics Inc. | KPTI | Frenkel Ran Chief Dev Operations Officer | 83,200 | $0 | 83,200 (Direct) | View |